Invokamet is a drug used to manage type-2 diabetes, combining metformin with canagliflozin, the main ingredient in Invokana.
Invokamet belongs to a class of diabetes medications called SGLT2 inhibitors (also known as gliflozins), and currently, there are three classes of drugs included in this category:
- Canagliflozin Class: Invokamet and Invokana
- Empagliflozin Class: Jardiance, Glyxambi and Synhardy
- Dapagliflozin Class: Farxiga and Xigduo XR
All of the drugs that work as SGLT2 inhibitors work on the sodium glucose-linked transporter 2 (SGLT2), a glucose transporter found in the duct system of the kidney. The SGLT2 and other glucose transporters assist in the reabsorption of glucose into the kidney. These medications work by the allowing the kidneys to remove the sugar from the body and excrete it into the urine.
Invokamet and Ketoacidosis
Invokamet has been linked to a severe side effect called ketoacidosis. When too many ketones are produced and build up in the blood, the blood becomes too acidic, and the condition may require hospitalization. Ketoacidosis may lead to diabetic coma, and may even lead to death if not quickly treated.
In May 2015, the FDA had received nearly two dozen reports indicating that patients taking Invokamet and other SGLT2 inhibitors were hospitalized due to their development of diabetic ketoacidosis. In December 2015, the FDA made an update to the label on Invokana warning consumers that there is an increased risk of developing ketoacidosis following its use.
Symptoms of Diabetic Ketoacidosis
Individuals taking Invokamet should be aware of the symptoms of ketoacidosis so they can monitor the drug’s effects on their body. Some of the most common symptoms of ketoacidosis include:
- Abdominal pain
- Breathing difficulty
- Confusion
- Fatigue or sleepiness that is uncharacteristic
- Feeling lightheaded like you are about to pass out
- Nausea
- Vomiting
Patients experiencing these symptoms on Invokamet should contact their physician immediately.
Other Severe Side Effects Associated with Invokamet
Invokamet has also received another FDA warning that led to the label revision of the drug in September 2015. This latest safety warning has furthered strengthened the warning regarding the increased risk of bone fractures with Invokamet use and has added additional information about Invokana decreasing bone mineral density in users.
Invokamet Lawsuit Information
If you or a loved one has developed ketoacidosis after using Invokamet or another SGLT2 inhibitor drug to treat diabetes such as Invokana, Jardinace, Glyxamni, Sunhardy, Farxiga or Xigduo XR, you may have a legal claim.
Investigations are currently being conducted by attorneys into the possibility of forming a class action lawsuit to represent individuals who have been harmed by these drugs. An Invokamet lawyer can review your case at no charge and can help you decide if filing an individual lawsuit or joining a class action lawsuit is right for you.
In general, diabetes medication lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Diabetes Medication Class Action Lawsuit Investigation
If you or a loved one suffered ketoacidosis or kidney failure after taking Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance or Glyxambi, you may have a legal claim. See if you qualify to pursue compensation and join a free diabetes medication class action lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Please select the diabetes medication(s) you have taken:*
-
Invokana (canagliflozin)
-
Invokamet (canagliflozin and metformin)
-
Farxiga (dapagliflozin)
-
Xigduo XR (dapagliflozin and metformin extended-release)
-
Jardiance (empaglifloziin)
-
Glyxambi (empagliflozin and linagliptin)
-
- When did you take the diabetes medication(s)?*
- Please select the symptoms you or your loved one were medically diagnosed with:*
-
Ketoacidosis
-
Kidney Failure
-
Not Listed (please detail the symptoms in the comments section if this is selected)
-
No diagnosis/injury
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 144) {gformInitChosenFields(‘#input_144_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_144_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_144_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [144, 1]) } );
The post Diabetes Medication Invokamet May Cause Ketoacidosis appeared first on Top Class Actions.
No comments:
Post a Comment